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n the current issue of the Journal, Miyata and colleagues1 describe the relation-
ship between coronary artery bypass grafting (CABG) procedural volume and
outcome in Japan. In reality, however, there are no high-volume programs in
this study. What the authors have actually provided us is the most extensive study
of low-volume and extremely low-volume CABG surgery in the literature. It comple-
ments previous studies from the United States that include some programs with low
volumes, and it provides a striking counterpoint to New York studies that are
weighted toward the high end of the volume spectrum.
This report illustrates the potential for good performance at low volumes, as well as
the statistical challenge of accurately measuring performance when sample sizes are
small. It raises a number of unresolved issues in the ongoing volume–outcome debate,
at least as applied to CABG surgery. For example, some payers and other stakeholders
continue to promote best-practice volume requirements that are increasingly beyond
the grasp of many programs, particularly as overall CABG volumes decrease nation-
ally. Is this appropriate policy given the available outcomes data? Because many
lower-volume programs function at a high level, can the public be protected while
at the same time not penalizing such excellent programs? Is there a rational lower vol-
ume limit for CABG surgery programs? Are there better ways to measure perfor-
mance that are less compromised by small sample sizes? Are there specific process
and structural approaches that might promote optimal functioning of small programs?
Is Low-volume CABG Surgery a Performance Problem or a Measurement
Problem?
CABG is unique: it is a mature, standardized procedure that is performed more fre-
quently than any other complex operation and that has also been scrutinized more
thoroughly. Notwithstanding the general validity of the volume–outcome relationship
for a number of medical conditions and surgical procedures, data from a variety of
sources suggest that many low-volume CABG providers achieve excellent results.
We believe the fundamental issue with low-volume CABG surgery is not inher-
ently poor performance but rather the difficulty in accurately measuring performance.
These 2 perspectives have quite different implications. If it were clear that low-vol-
ume CABG providers were uniformly poor performers, immutably limited by their
lack of sufficient ‘‘practice,’’ then the only reasonable solution would be volume
thresholds. For some highly complex but very infrequently performed procedures,
such as esophagectomy or pancreatectomy, this might well be a justifiable approach.
In reality, however, excellent performance is achieved by many CABG providers
whose volumes, although they might number in the hundreds annually, do not meet
the thresholds of organizations like the Leapfrog Group (450 procedures per year).
In this circumstance, volume standards would unfairly stigmatize or penalize such
high-quality but low-volume providers. Furthermore, at a time when CABG volumes
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Shahian and Normand Expert Commentaryare decreasing, such thresholds could also have unintended
negative consequences. Given the importance of cardiac sur-
gery to most institutions, failure to meet guidelines for ‘‘cen-
ter of excellence’’ status or premium reimbursement might
have substantial adverse implications. This could result in
a perverse incentive to relax appropriateness criteria to
meet volume thresholds, which might have a net negative ef-
fect on the health system.
If one views low-volume CABG providers as a heteroge-
neous group, many of whom provide excellent results, then
the main issue is how to accurately measure the performance
of individual programs, a challenge with small sample sizes
and limited mortality events. More comprehensive and robust
approaches to performance measurement could be developed
that are less limited by such concerns, and specific program-
matic initiatives could also be implemented to facilitate high
performance in smaller programs.
We will examine both the evidence for a CABG volume–
outcome relationship as well as statistical problems with as-
sessing performance in low-volume programs. Findings from
the study of Miyata and colleagues1 will be reviewed in the
context of these two issues. Finally, recommendations will
be presented to enhance both performance and its measure-
ment in low-volume CABG programs.
Previous CABG Volume–outcome Studies
Although the strength of the CABG volume–outcome rela-
tionship is probably exaggerated in some studies by failure
to account for sample size and clustering (eg, through the
use of hierarchical models),2 there is little question that
some association exists. This was evident in the original
work of Luft and associates3 nearly 30 years ago, and it has
been demonstrated in numerous subsequent studies, includ-
ing those from the modern era.4-11 The strongest data support-
ing a volume–outcome association come from New York,
although these studies include very few programs that are
truly low volume, and their findings might not be generaliz-
able. In 2004, for example, there were 39 New York programs
providing isolated CABG surgery, and 75% of these pro-
grams had volumes of greater than 214 procedures. It remains
uncertain whether the CABG volume–outcome relationship
applies to all patients10 or primarily to those at higher risk.12,13
Notably, the volume strata and mortality ranges for CABG
are quantitatively unique among complex procedures in which
the volume–outcome association has been investigated. In
studies by Birkmeyer and associates4 using claims data on
901,667 Medicare patients, low and high volume hospital
categories for CABG were, 230 procedures and. 849 pro-
cedures respectively, with an absolute mortality difference of
only 1.1% (4.5% vs 5.6%) between these two extremes. In
contrast, the low and high volume ranges were ,1 and .16
procedures for pancreatecomy and ,2 and .19 procedures
for esophagectomy, with absolute differences in adjusted
mortality that were orders of magnitude greater (16.3% vsThe Journal of Thor3.8% for pancreatectomy, 20.3% vs 8.4% for esophagectomy)
than those for CABG.
Perhaps because it is a mature and frequently performed
procedure, the volume–outcome association for CABG is
weak. Studies by Peterson and coworkers13 using 2000–2001
data from the Society of Thoracic Surgeons (STS) National
Adult Cardiac Database, adjusted for risk factors and cluster-
ing, demonstrated only a 0.07% decrease in mortality for
every additional 100 procedures (P 5 .004). Because there
was substantial variability in mortality in all strata of volume,
there was limited ability to discriminate among providers
based solely on volume. Similar findings were noted in a study
of 228,738 patients by Rathore and associates7 using data
from the 1998–2000 Nationwide Inpatient Sample. In both
studies, the vast majority of low-volume providers are distrib-
uted widely and symmetrically about the mean, with variation
increasing at progressively smaller program volumes. Scatter-
plots of observed mortality versus volume in these studies
look strikingly similar to the funnel appearance of the 95%
confidence intervals of a binomial event, with an average oc-
currence rate of about 2% to 3%, taken at various sample
sizes.14 This is illustrated in Figure 1, a scatterplot based on
the 2004 isolated CABG results from Massachusetts, New
York, Ontario, and California. Superimposed scatterplot
smoothers are roughly horizontal, showing little volume–out-
come association. Much of the variability in mortality at low
volumes, regarded by many as an indicator of inconsistent
performance, is quite likely explained by sampling error.
Outcomes Profiling in Low-volume Programs
An alternative approach to volume thresholds is outcomes
profiling. Public reporting of CABG outcomes is favored
by many policymakers and has been mandated by law in
states like New York and Massachusetts. Properly performed
(by no means a trivial caveat), such reports are reasonably
objective, they provides transparency and accountability, and
they address the most important interest of patients: operative
survival. However, they are the most demanding in terms of
the need for high-quality data, audit and validation, and
appropriate analytic methodologies. Even with larger sample
sizes, comparative assessment of provider performance can
be challenging, especially when based on a single outcome
such as mortality. This becomes increasingly problematic
as sample sizes (program volumes) decrease, a feature illus-
trated previously with regard to volume–outcome studies.
Outcomes profiling generates estimates of provider per-
formance derived from a snapshot in time, typically a year
of clinical activity. Such observed results are used to estimate
‘‘true’’ underlying program quality, ideally with confidence
intervals that indicate how certain we are about this point
estimate. As noted previously, the statistical confidence inter-
vals around point estimates of mortality, an infrequent
binomial event, become quite wide with small sample sizes
(annual program volumes).5 Much of the variation of annualacic and Cardiovascular Surgery c Volume 135, Number 6 1203
Expert Commentary Shahian and NormandFigure 1. Scatterplot of 2004 coronary artery
bypass grafting (CABG) volume (x-axis) and risk-
adjusted mortality rates (RAMR; y-axis) from
New York, Massachusetts, California, and On-
tario. Superimposed scatterplot smoothers are
relatively flat. There is wide variability in out-
comes at low volume, which is predominately
sampling error. In the 2001–2004 Japanese CABG
experience reported by Miyata and colleagues,1
approximately 94% of programs would lie to the
left of the vertical line drawn at a volume of 100
procedures annually (estimated by averaging the
results over these 4 years). Individual hospital
data from Japan were not available.mortality rates among low-volume programs (eg, fewer than
100–150 procedures per year), as shown in Figure 1, can be
largely explained by random statistical fluctuation, and this in
turn limits the ability to draw firm conclusions about program
quality.5,15 In studies by Dimick and colleagues,15 CABG was
the only complex procedure performed with sufficient fre-
quency by most programs to detect a doubling of mortality rate
based on 3-year aggregate data. However, as CABG mortality
rates continue to decrease, the sample sizes necessary to detect
meaningful differences increase correspondingly.
The Japanese Experience: Extremely Low-volume
CABG Surgery
This brings us to the study by Miyata and colleagues1 in the
current issue of the Journal, an extreme and revealing illus-
tration of both the ‘‘problems’’ of low-volume surgery, as
well as some potential solutions. The authors describe the
demographics of CABG programs in Japan, where annual
volumes are so uniformly low that there is simply no US an-
alog.3,4,7 In Japan there has been limited regulatory oversight
of cardiac surgery program proliferation or performance prior
to the past few years. Relative to their population size, lower
incidence of coronary disease, and number of isolated CABG
procedures, the number of CABG providers in Japan far
exceeds that of any publicly reported US states or the prov-
ince of Ontario, as demonstrated in Table 1. Overall, 76%
of Japanese programs perform fewer than 50 CABG proce-
dures annually. Only 5.6% of 540 Japanese cardiac surgery
programs (representing most of the programs in the country)
performed at least 100 CABG procedures annually between
January 2001 and December 2004, and 24.6% of programs
performed fewer than 15 procedures annually. Median an-1204 The Journal of Thoracic and Cardiovascular Surgery c Junual CABG volume was 28 procedures per year during this
period (interquartile range, 15–49 procedures), and the aver-
age annual volumes ranged from 0.25 to 293 isolated CABG
procedures. Using a threshold of 150 procedures annually,
98.3% of Japanese programs would be classified as low or
very low volume by US standards. Based on the findings of
Miyata and colleagues,1 94% of Japanese CABG programs
would fall to the left of the vertical line (annual volume of
100 procedures) in Figure 1, which would be very low vol-
ume by US and Canadian standards.
By comparison, during 2000–2001, the median volume of
CABG procedures among STS National Adult Cardiac Data-
base participants was 253,13 notably still less than the
Leapfrog threshold of 450 procedures. At the high-volume
extreme, New York has had a longstanding aggressive
approach to monitoring and improving cardiac surgery qual-
ity.16 Between 1997 and 1999, median CABG volume at
New York hospitals was 527 procedures (mean, 577 proce-
dures; interquartile range, 331–816 procedures). Only 2.14%
of patients undergoing CABG were treated at hospitals per-
forming fewer than 200 such procedures annually,10,11 and
only about one tenth of New York hospitals had annual
CABG volumes of less than 200 procedures.
Given the consistently low volume of most Japanese
CABG programs, their overall results will come as a surprise
to many. The most complete data source for this study was
a survey of 540 programs collected by the Japanese Associ-
ation for Thoracic Surgery, including almost all programs in
the country. The overall mortality rate was 1.9%, and mortal-
ity for all volume categories above 41 to 50 procedures per
year was less than 2%, which is comparable with rates in
most US state and national CABG registries. Mortality ratesne 2008
TABLE 1. 2004 CABG volumes, numbers of programs, and outcomes for selected states and provinces compared with estimated annual Japanese experience
04 isolated CABG
volume, median
(min-max)
2004 crude
operativey
mortality (%)
2004 RAMR (%),
median
(min-max)z
120 (4–975) 3.29 3.30 (0–12.5)
290 (102–755) 1.98 NA
287 (101–537) 2.01 2.09 (1.50–3.95)
288 (1–1188) 2.09 2.01 (0–3.6)
647 (305–945) 1.24 1.11 (0.46–4.11)
195 (56–888) 2.31 NA
8 (0.25–293) (zz) 1.92 (zz) NA
io: Statistics Canada, Canada's National Statistics Agency,
ses (http://www12.statcan.ca/english/census06/data/topics/
&IPS5&METH50&ORDER51&PID588984&PTYPE588971&
: Statistics Bureau, 2005 Population Census, First Basic
rgical intervention, regardless of where the patient died; for
ed, regardless of the number of days after the procedure; for
30-day deaths.
ta. CA Office of Statewide Planning and Development; http://
er; http://www.nj.gov/health/healthcarequality/documents/
January 1, 2004–December 31, 2004. Department of Health
.ny.us/diseases/cardiovascular/heart_disease/docs/cabg_
p://www.ccn.on.ca/memberpdfs/Report-CAB-Surg-Ontario-
ery 2004; http://www.phc4.org/reports/cabg/04/docs/cabg
iyata and colleagues, almost all CABG programs in Japan.
sample of overall programs.
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entaryRegion
Population
aged $18 y*
2004 isolated CABG
admissions
2004 CABG
admissions
per 100,000 adults
2004 CABG
programs
2004 CABG programs
per 1000 CABG
admissions
20
Californiax 26,924,935 19,101 70.9 120 6.3
New Jerseyk 6,635,222 6177 93.1 17 2.7
Massachusetts{ 4,988,309 3986 79.9 14 3.5
New York# 14,791,841 12,988 87.8 39 3.0
Ontario** 9,439,990 7196 76.2 11 1.5
Pennsylvaniayy 9,635,748 13,359 138.6 60 4.5
Japan
(current study)zz
105,943,707 20,000 (zz) 18.9 5401 27 2
CABG, Coronary artery bypass grafting; RAMR, risk-adjusted mortality rate; NA, not applicable.
* For the US States: US Census Bureau Population Estimates 2006 (http://www.census.gov/popest/states/asrh/SC-EST2006-01.html); for Ontar
Age and Sex for the Population of Canada, Provinces, Territories, Census Metropolitan Areas and Census Agglomerations, 2001 and 2006 Censu
RetrieveProductTable.cfm?ALEVEL53&APATH53&CATNO5&DETAIL50&DIM5&DS599&FL50&FREE50&GAL50&GC599&GK5NA&GRP51
RL50&S51&ShowAll5No&StartRow51&SUB50&Temporal52006&Theme566&VID50&VNAMEE5&VNAMEF5&GID5837983); for Japan
Complete Tabulation (http://www.stat.go.jp/English/data/kokusei/2005/kihon1/00/hyodai.htm).
y Operative mortality was defined as follows: for California, Massachusetts, Ontario, and Pennsylvania, all deaths occurring within 30 days of su
New Jersey, all deaths up to 30 days after surgical intervention or deaths occurring during the hospital stay in which the operation was perform
New York, all deaths within the hospitalization, all discharges (alive or dead) to hospice care except those still alive at 30 days, and all other
z New Jersey and Pennsylvania present risk-adjusted mortality rates graphically and do not report specific numbers.
x California CABG Outcomes Reporting Program (2007). Coronary Artery Bypass Graft Surgery in California: 2003–2004 Hospital and Surgeon Da
www.oshpd.ca.gov/HID/Products/Clinical_Data/CABG/03-04fullreport.pdf.
k New Jersey Department of Health and Senior Services (May 2007). Cardiac Surgery in New Jersey 2004. Office of the Commission
cardconsumer04.pdf.
{ Massachusetts Data Analysis Center (October 2006). Adult Coronary Artery Bypass Graft Surgery in the Commonwealth of Massachusetts:
Care Policy, Harvard Medical School; http://www.massdac.org/reports/CABG%202004.pdf.
# New York State Department of Public Health (June 2006). Adult Cardiac Surgery in New York State: 2002–2004; http://www.health.state
2002-2004.pdf.
** Guru V, Wang J, Donovan L, Tu JV (June 2006). Report on Coronary Artery Bypass Surgery in Ontario: Fiscal Years 2002–2004; htt
2002-2004.pdf.
yy Pennsylvania Health Care Cost Containment Council (February 2006). Pennsylvania's Guide to Coronary Artery Bypass Graft Surg
2004report.pdf.
zz Miyata and colleagues (current study).1 2004 volume estimated from 2001–2004 aggregate data. Number of programs (540) represents, per M
Crude mortality rate is based on 2001–2004 aggregate data. Risk-adjusted results are not presented because they are based on only a small
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Expert Commentary Shahian and Normandfor programs with annual volumes of less than 41 to 50
procedures ranged from 2.42% to 3.15%.
Because these voluntary survey data lacked both adequate
risk adjustment and careful audit, the authors also studied
a small subset of 36 highly selected Japanese programs that
contributed data to the Japanese Adult Cardiovascular
Surgery Database, a clinical registry modeled after the STS
National Adult Cardiac Database. Table 2 of their article
demonstrates that patients in these programs had a distribu-
tion of risk factors not dissimilar to what would be observed
in many US CABG registries. Unadjusted 30-day mortality
was 1.88%, and operative mortality (including in-hospital
deaths occurring after 30 days) was 2.55%. Risk-adjusted
30-day mortality was 1.50% for programs with an annual
volume of 51 or more procedures and 2.14% for hospital vol-
umes of 31 to 50 procedures.
What Do the Japanese Results Tell Us?
These aggregate data illustrate the feasibility of achieving
good overall performance at low volumes, but they do not
address the problem of accurately measuring individual hos-
pital performance based on small samples. Although individ-
ual hospital volumes and outcomes are not provided by the
authors, one would presume that at median volumes of 28
procedures per year, random sampling variation alone could
result in mortality rates from zero to greater than 10% for
some programs, regardless of their underlying true perfor-
mance. With volumes and sampling variability in this range,
there is virtually no practical way to monitor quality in any
meaningful time frame.
What are the implications of these generally favorable
results for policymakers in Japan and the United States? In
our view, despite the reasonable overall results, this study
certainly should not be interpreted as justification for reduced
vigilance of low-volume programs. Rather, it is just another
example, albeit a dramatic one, of how low-volume programs
can often function quite well. This study does not address the
issue of identifying individual high- and low- performing,
low-volume programs.
The Japanese study also leaves many other important
questions unanswered. For example, there are few if any truly
high-volume programs in this study with which to compare
the performance of their otherwise low-volume centers.
Overall Japanese CABG mortality rates seem reasonable,
but are they optimal given their demographics and current
resources? If Japan had a number of true high-volume pro-
grams, would their mortality rates for the same patient popu-
lation be even lower than those currently being reported?
How Can Low-volume Programs Perform at High
Levels?
These seemingly good results should also lead us to inquire
more deeply into the structures and processes of care at these1206 The Journal of Thoracic and Cardiovascular Surgery c Julow-volume Japanese programs. Even with the obvious ca-
veats regarding sample size and risk adjustment, there is no
compelling evidence in these results or elsewhere in the liter-
ature of a CABG mortality crisis in Japan. Perhaps there are
lessons from this extreme example that might be applicable to
less extreme but smaller programs in other countries. To
some extent there is truth in the axiom that practice makes
perfect, and some level of repetition is essential for any
complex task. But repetition is not the only or perhaps
even the best path to high performance. Countless repetitions
of suboptimal practices only reinforce those practices and
leads to no improvement whatsoever. Identification of opti-
mal practices affords the opportunity for substantial learning
with every repetition, even if the overall number of repeti-
tions is smaller.
Why have so many programs been able to perform at least
reasonably well in this very low-volume environment? Are
there unmeasured differences in case mix or selection criteria
compared with the US experience? Is there a proportionately
higher volume of other types of cardiac surgery, including
CABG combined with other procedures, that maintains
both technical proficiency for individual surgeons and also
effective team functioning? Are there particular surgical tech-
niques, perfusion methodologies, or standardized periopera-
tive care routines that have enhanced the overall outcomes
of their patients?
Team functioning can affect CABG outcomes to a greater
extent than in other procedures. Cardiac surgery is a team
effort, a complex interaction of surgeons, assistants, nurses,
anesthesiologists, and perfusionists. Low-volume surgeons
have better results when operating at high-volume hospi-
tals,8,11 presumably because they benefit from their standard-
ized processes and team functioning. By the same token, even
a higher-volume surgeon might not function optimally when
working with an unfamiliar team. In a recently reported
California experience, much of the salutary effect of being
a higher-volume surgeon was negated if the surgeon did not
perform these cases in the same institution (and presumably
with the same team).17
In the Japanese experience most surgeons work with their
own teams and function in only one hospital. Many cases are
staffed by 2 attending surgeons, and the authors also note the
importance of physician oversight of postoperative intensive
care unit care. Finally, because of their insurance system,
there is less pressure for early discharge, which might reduce
the frequency and adverse effect of unrecognized late compli-
cations and readmissions.
Recommendations
In light of past research and current findings, we can envision
a number of approaches to low-volume CABG surgery that
might have applicability both in Japan and elsewhere.ne 2008
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Is there a lower acceptable limit for CABG volume? Despite
our strong support of direct outcomes measurement and gen-
eral skepticism of volume thresholds, it is intuitively difficult
to believe that optimal CABG results can be achieved in an
institution performing a few procedures a month, the situation
in many Japanese programs. Perhaps there are unique geo-
graphic, demographic, cultural, or political considerations
that support the perpetuation of the most extreme low-volume
Japanese programs, but these should be individually re-
viewed. Within this group, it is certainly possible that some
programs perform well. However, at such extreme low
volumes, there is no possibility of accruing sufficient data to
reliably measure performance, at least in a reasonable time
frame. Consolidation of the most extreme low-volume pro-
grams would be, in our opinion, a significant step toward
a more rational CABG delivery system in Japan (and else-
where). How to define this category of programs is challeng-
ing, but in many areas fewer than 100 to 125 isolated CABG
procedures annually might be a reasonable starting point for
discussion. The exception might be a center performing a large
number of other cardiac procedures combined with CABG.
Low-volume CABG Surgery: Improving Performance
Assessment
There are many smaller programs above the extreme low end
of the volume spectrum, and for them it is essential to develop
better, more comprehensive, and timely methods to monitor
performance. This will necessitate uniform adoption of some
currently available methods, as well as the implementation of
some more innovative approaches.
Clinical data registry
Although participation in a clinical data registry is important
for all cardiac surgery programs, it should be absolutely man-
datory for lower-volume programs to maximize the available
information regarding patient case mix, appropriateness of
surgical indications, and risk-adjusted performance. In Japan,
the Japanese Adult Cardiovascular Surgery Database would
seem to be an appropriate instrument with which to imple-
ment such a program, particularly given its established mech-
anisms for audit and validation.
Statistical methodologies
For low-volume programs, performance estimates should be
based on multiple years of aggregate data and can be reported
as a rolling average. This provides larger sample sizes, albeit
at the expense of using some data that are several years old
and perhaps less relevant to current conditions. The use of
hierarchical statistical models is also recommended to address
sample size and clustering issues.18-20The Journal of ThorSeveral graphical methods can also aid in monitoring
program performance. Funnel plots have been advocated for
performance measurement14 because they explicitly depict
the increasing random statistical uncertainty of a binomial
event at small sample sizes. The results from low-volume
programs look much less anomalous when viewed from this
perspective.
Another graphical approach to monitoring performance,
the CUSUM (Cumulative Sum) chart and its variants,21 has
also been used increasingly in recent years. These methods
provide sensitive, real-time monitoring with the potential
for earlier detection of deteriorating trends in performance,
and they might be less dependent on the accrual of large
sample sizes.
Composite measures
Composite measures of CABG quality have recently been
developed and implemented by the STS,22,23 and these
might be particularly advantageous in following small pro-
grams that have a correspondingly low number of mortality
end points. Because they contain more end points encom-
passing multiple domains of care (not just mortality), such
composites are useful in assessing and comparing quality.
Additional end points include both morbidity outcomes
measures and process measures, the latter including use of
internal thoracic artery grafts and medications proved to
reduce long-term cardiovascular risk. The STS composite
CABG measure has been shown to enhance the ability to
differentiate performance among providers.
Appropriateness
Given the pressure to attain volume thresholds, it is parti-
cularly important to monitor procedures at lower-volume pro-
grams for appropriateness. This can be done by using standard
criteria established by the American College of Cardiology/
American Heart Association.
Patient satisfaction
Measures of patient satisfaction are becoming increasingly
important, such as the Consumer Assessment of Healthcare
Providers and Systems program. Such measures can be par-
ticularly useful in assessing the relative value to patients of
having surgical intervention in their smaller local hospital
versus traveling to a larger tertiary center.
Direct expert review
Finally, in some situations regulators might determine that
a particular low-volume program must undergo case-by-
case monitoring by an external expert panel as the quid pro
quo for continued licensure. This expert committee could
meet on a regular basis to review both appropriateness and
outcomes for each case.acic and Cardiovascular Surgery c Volume 135, Number 6 1207
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Adherence to best practice guidelines
In addition to using more reliable and comprehensive mea-
sures of performance, smaller programs must have strong in-
centives to use established best practices. Based on practices
developed at larger institutions, these might help to offset
their relatively smaller experience.
Case selection
Except for emergencies in which patient transfer is not feasi-
ble, smaller programs should be highly selective in the type
of cases they perform. Although the individual surgeons
might be skilled and experienced in more complex opera-
tions, the experience of the team will likely be limited, as
will the other hospital resources necessary to care for such
patients perioperatively.
Sponsorship and oversight by tertiary centers
Ideally, low-volume programs should not function in isola-
tion. When feasible, they should be sponsored by larger
tertiary centers that share the responsibility for ensuring and
improving their quality. Standardized processes of care can
be directly imported from the tertiary center, and there might
be periodic exchange of staff to bring new ideas and tech-
niques. Teaching conferences and lectures can be scheduled
regularly, either live or by means of videoconferencing, and
there might even be resident rotations from the tertiary center
to the low-volume program. The low-volume center may
enjoy some volume purchasing advantages because of its
affiliation with the larger center. Sponsoring institutions share
joint responsibility with the low-volume center for staff cre-
dentialing, scrutiny of outcomes, and remediation when ap-
propriate. Finally, the low-volume center has an established
referral pathway for more complex and severely ill patients.
Because they are part of the larger program, there is no incen-
tive to retain cases for which they are not equipped (patient-
program mismatch). A prototype for such an arrangement
has been in place in Massachusetts for a number of years
and has functioned quite well.
Team functioning
Small programs should generally be restricted to one surgical
practice group to minimize the potentially adverse effect of
competition for a limited number of cases. This structure
also maximizes the joint experience of the single surgical
team, an extremely important consideration, particularly
given the recent report from California.17 It may be useful
to have two attending surgeons scrub, particularly for more
difficult cases, apparently a common practice in Japan. This
maximizes the experience of both surgeons and provides
additional peer assistance.1208 The Journal of Thoracic and Cardiovascular Surgery c JuTeam functioning and cohesiveness can also be fostered
through crew resource management training, simulations,
and regular team visits to tertiary centers.
Summary
Volume is only a proxy for outcomes, such as risk-adjusted
mortality, and the volume–outcome relationship holds true
only on average.9 Because of the weak relationship of
CABG outcomes to volume and the large sampling variation
of observed mortality at low volume, attempts to improve
CABG performance primarily through volume thresholds
are problematic, except at the extreme. Direct outcomes mea-
surement is a much more reliable approach for both account-
ability and consumer guidance, and it is more predictive of
subsequent program performance.24 From this perspective,
the greatest advantage of volume thresholds is to increase sam-
ple sizes to enable more precise assessment of risk-adjusted
outcomes,25 the real metric on which we should focusing.
Many low-volume programs perform at a high level.
Although it is appropriate to discourage extremely low-
volume programs, many lower-volume centers not meeting
Leapfrog or similar thresholds do provide high value to the
public. Approaches should be considered that optimize the
functioning of such units, and more comprehensive tech-
niques should be used to facilitate performance monitoring
in lower-volume settings.
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